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Background Adolescents with congenital heart disease (CHD) con-
stitute a growing population of individuals for whom a well-planned
and well-executed ‘‘transition process’’ is essential. Transition
program should include education about medical conditions and
promote skills in decision-making and self-care. To improve their
level of health related knowledge, a structured education pro-
gram was implemented in a transition CHD program. This study
aimed 1/to evaluate level of knowledge of adolescents who received
structured CHD education as compared to adults who did not,
2/to evaluate whether patients who received structured education
improve their knowledge.
Methods and results 42 adolescents (16± 2 years old, 21 girls)
were included in a structured CHD education program and were
compared to 22 adults (33± 7, 6women) with CHD who have
never followed education program. Knowledge in adolescents
was assessed before and after the educational program using
questionnaire exploring speciﬁc issues related to CHD. A same ques-
tionnaire was used in non-educated adult patients. The mean total
knowledge score in the educated adolescent group was signiﬁ-
cantly higher as compared to the non-educated adult with CHD
(score = 15.6/20± 3.6 vs. 12.5± 4.5, P < 0.01). Provision of struc-
tured CHD education and female sex were determinant of higher
levels of knowledge. A signiﬁcant improvement of knowledge was
observed in adolescents group after CHD education program (range
of increase was 23 to 44%). This result was not inﬂuenced by age,
sex, education level, socio-economic status of parents and disease
complexity, and persists at 10months mean follow-up.
Conclusion A structured education program was associated with
a higher level of knowledge, above all in male CHD patients. Educa-
tion at transition period has a signiﬁcant impact on the adolescent
knowledge. Structured education program should improve adult
CHD understanding of their heart condition, and could prevent
potential complications.
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Methods Retrospective single-centre analysis of long-term post-
transplant outcome, with chart collection of clinical and
paraclinical data [this study assessed the long-term outcome of
heart (HTx) and heart-lung transplantation (HLTx) in patients with
congenital heart disease (CHD) and children with non-congenital
cardiac or pulmonary disease.]
Results From 1984 to 2013, 111 ﬁrst-HTx, 5HLTx and 6 re-HTx
were performed (62males), in patients aged 11.7± 8.2 y: 96 (79%)
aged < 18 y. Cardiopathy included 61 cardiomyopathies (50.8%),
50 CHD (41.7%), 6 retransplants (5%). HLTx included 1 Eisenmenger,
1 PPHT, and 2 pulmonary diseases. Patients with cardiomyopa-
thy were younger than CHD (8.7 y vs. 14.9 y). Seventeen (14%)
patients had circulatory mechanical support as bridge to trans-
plant. Acute rejection occurred more frequently within the ﬁrst
year post-transplant or > 5th year in non-compliant teenagers. Over-
all, 33 patients died (27%), 3.5± 4.6 y post-Tx (1 day to 16.4 y, med
1.5months), due to early multivisceral failure in 6 (18%), pulmonary
hypertension in 3 (9%), acute rejection in 7 (21%), graft coronary
disease in 6 (18%), sepsis in 5 (15%) and miscellaneous in 6. Graft
coronary disease occurred in 15 (12.4%): 4 had re-HTx, 6 died and
5 are alive. Five lymphoma occurred, 4months to 14 y after HTx,
cured in 4 (1 died). Patients survival was 85% at 1 y, 81% at 5 y, 70%
at 10 y and 61% at 20 y post-transplant. Graft survival rates were
respectively 82%, 68% and 52% at 5 y, 10 y and 20 y post-transplant.
Survival did not differ with pretransplant disease, age, gender, pre-
transplant mechanical support. Mortality was higher in patients with
coronary disease (40%) than those free from (25%).
Conclusion Long-term prognosis after HTx and HLTx is favourable.
Graft coronary disease is the main cause of failure, less frequent
than in the adult non-CHD heart-transplanted population.
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